Blog

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / For decades, the global debate over plastic waste has been defined more by ambition than by results. Policymakers set targets, global brands pledged billions, and NGOs pressed for accountability. Yet the frameworks underpinning recycling were never designed to succeed. They focused narrowly on PET bottles and food-grade rPET, leaving industrial polymers, automotive resins, textiles, and electronics out of the loop. With such gaps, even the most determined programs fell short.

Singapore has decided to change that equation. Its launch of the world’s first national plastic passport program-developed with research powerhouse ASTAR and enabled by SMX (NASDAQ:SMX)-turns recycling from a patchwork of good intentions into true national infrastructure. At its core, SMX technology permanently marks plastics at the molecular level, providing them with a verifiable global passport that tracks their entire lifecycle from manufacturing through recycling. The result is a system built on proof rather than promises, one that takes sustainability out of the realm of aspiration and into execution.

And with it, Singapore secures a first-mover advantage with positive implications that can reach far beyond its borders. Don’t mistake the intent, here.

Cementing ASEAN’s Testbed for the Future

Singapore’s leadership is not only about environmental stewardship; it is also about economic and geopolitical positioning. ASEAN is on track to become one of the world’s largest consumer markets, and aligning its production standards with those of Europe, Japan, and the U.S. will define future trade flows. By embedding traceability into plastics now, Singapore positions itself as the testbed where multinational brands, regulators, and manufacturers converge. Whoever sets the rules in Singapore sets the precedent others will follow.

The numbers underscore the opportunity. Singapore generates about 957,000 tonnes of plastic waste annually, of which 94% is incinerated. Redirecting just a third of that waste into an SMX-verified loop would avoid S$27 million in incineration fees while unlocking S$75 million in certified resin value – a compliance dividend worth over S$100 million per year. Replicated across ASEAN, this blueprint represents an addressable market of about S$4.2 billion annually. What might look like a costly regulatory mandate elsewhere is being reframed in Singapore as a lever for competitiveness, investment, and resilience.

This is the power of first-mover advantage. Just as Singapore became a hub for global finance and logistics by building trust and infrastructure ahead of its peers, it is now doing the same with plastics sustainability. The country’s early action ensures it will be the reference point for standards, trading systems, and cross-border compliance throughout Asia.

SMX Provides the Technology Backbone For plastics

Singapore earns the spotlight for leading, but it’s SMX’s technology that makes such leadership viable. SMX embeds invisible molecular markers into plastics, providing them with a verifiable global plastics passport that can be tracked, trusted, and certified worldwide. That passport allows brands, recyclers, and regulators to prove claims, certify value, and create auditable data across borders. In practice, it converts recycling from a compliance burden into a system of tradable assets.

Every kilogram of plastic that carries an SMX-provided global passport can also be paired with a Plastic Cycle Token (PCT), a one-to-one financial instrument backed by the molecular marker and its audit trail. Unlike carbon credits, which have suffered from accountability issues, PCTs are transparent, measurable, and auditable. They allow recyclers to monetize verified output, brands to hedge compliance risks, and investors to treat recycling as a new commodity class. In short, SMX turns waste into wealth and sustainability into a driver of profitability.

SMX Earns Its Defining Moment On The World Stage

For SMX, the partnership with Singapore is a defining moment. Years of research and pilots have culminated in the first national deployment of its platform, endorsed at the government level and designed to serve multinational stakeholders. This isn’t a pilot; it’s proof at scale. The nation gains its first-mover advantage, ASEAN gains a model ready for replication, and SMX gains validation as both technology enabler and market architect.

What Singapore is showing the world is simple: intent alone is not enough. Proof is what matters. By marrying ambition with infrastructure, and sustainability with economic reward, the nation has staked its claim as the global leader in plastics sustainability. And in doing so, it has given SMX the proving ground to turn decades of work into a category-defining market model.

References

1. National Environment Agency (NEA). Waste & Recycling Statistics 2014 – 2023. Singapore: NEA; 2024.

2. Shunpoly.com. “How Much Plastic Is Wasted Each Year in Singapore?” Accessed 5 August 2025.

3. National Environment Agency (NEA). Waste-Statistics & Overall Recycling (interactive dashboard). Updated 2024; accessed 5 August 2025.

4. National Environment Agency (NEA). Mandatory Packaging Reporting portal. Accessed 5 August 2025.

5. Singapore Statutes Online. Environmental Public Health (Public Cleansing) Regulations – Incineration gate-fee schedule; revised 2024.

6. National Environment Agency (NEA). “New Licensing Regime for General Waste Disposal Facilities.” Technical brief & dialogue-session slides; 2024.

7. Nasdaq.com. “SMX Announces Planned Launch of World’s First Plastic Cycle Token.” Press release; 2024.

8. Yahoo! Finance. “SMX Plastic Cycle Token Is a Functional Market-Driven Solution…” News article; 2024.

9. Los Angeles Tribune. “Carbon Credits Had Their Day… Now the SMX Plastic Cycle Token…” Feature article; 2025.

10. National Environment Agency (NEA). Refuse Collection Fees for Households. Revised 2024; accessed 5 August 2025.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

The acclaimed television series will highlight how TurboTenant has helped more than 800,000 investors nationwide through its user-friendly platform.

CONTACT
Liz Plummer
Executive Producer
Trending Today
Liz@trendingtoday.com
P: 561.290.9820
W: www.trendingtoday.com

SOURCE: Trending Today

View the original press release on ACCESS Newswire

Veteran drone executive to expand enterprise sales for U.S.-made components

ORLANDO, FL / ACCESS Newswire / September 4, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced the appointment of Craig McIntyre as Vice President of Enterprise Sales.

McIntyre brings more than 20 years of leadership in sales and business development, including senior roles building drone solutions ecosystems and navigating government procurement. Most recently, he served as Head of Commercial Market Development for Drone Solutions at BT Group, where he oversaw counter UAS and infrastructure contracts, introduced the world’s first 4G drone SIM, and launched national drone survey services. He has also founded and scaled multiple start-ups focused on UAV, counter-UAS, and emerging technology markets.

At Unusual Machines, McIntyre will lead enterprise customer engagement for the company’s high-performance motors and critical drone components. His mandate includes developing strategic partnerships, supporting the company’s expansion of U.S. manufacturing, and ensuring customers have dependable access to the parts they need. McIntyre will report to Stacy Wright, Executive Vice President of Revenue.

“Enterprise customers are central to our strategy, and Craig is the perfect leader to help us capture this opportunity,” said Stacy Wright, EVP of Revenue at Unusual Machines. “His background navigating complex procurement processes and building OEM and channel partnerships will strengthen our commercial approach and reinforce the investments we’re making in domestic production.”

“This is an exciting time to be joining Unusual Machines,” said Craig McIntyre, Vice President of Enterprise Sales. “Customers are looking for mission-ready motors and components backed by trusted U.S. supply chains, and I’m eager to build the systems and partnerships that continue to make working with us both seamless and reliable.”

About Unusual Machines

Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.

For more information, please visit www.unusualmachines.com.

Investor Contact

CS Investor Relations
investors@unusualmachines.com

Media Contact

media@unusualmachines.com

SOURCE: Unusual Machines, Inc.

View the original press release on ACCESS Newswire

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their launch of ‘Human Data Trials’ – a new category of pre-clinical research that gives drug developers early, predictive insights from real, functional human organs. The round was co-led by America’s Frontier Fund and Sierra Ventures with participation from Roger Ferguson, former Vice Chair of the U.S. Federal Reserve and a member of the Board of Directors at Alphabet, and other existing investors. This brings Revalia’s total funding to $19.5 million.

Despite billions spent on R&D each year, more than 90 percent of drug candidates fail to reach market approval. One of the key reasons is the poor translation from preclinical models to human biology. Animal models and in vitro systems often fall short in predicting how therapies will behave in real patients, leading to delays, cost overruns, and failed trials. Revalia is addressing this breakdown by delivering on-demand access to functional human data through its Human Data Trials – rigorous testing conducted on perfused, human organs maintained under clinical conditions.

“The old model of drug development is broken – decade-long timelines, 90% failure rates, and billion-dollar costs are no longer sustainable,” said Greg Tietjen, co-founder and CEO of Revalia Bio. “We’re building a new paradigm that allows us to transform the loss of one patient into the future of human-centered development – a new model grounded in real human data, not approximations,” he added.

Revalia enables biotech and pharmaceutical companies to evaluate new therapies using data from real human organs, revived and sustained through proprietary perfusion technology. These organs are donated with informed consent from the families and would otherwise be unusable for clinical transplant. This approach improves the accuracy of preclinical data, reduces development costs, and eliminates risks to living patients.

“We see every donated organ as a legacy,” said Kourosh Saeb-Parsy, Chief Medical Officer at Revalia Bio. “Our job is to turn that gift into progress-not just for one trial, but for a new opportunity for developing life-saving medicines,” he added.

The platform unifies data from perfused human organs, donor medical histories, and high-resolution digital analytics through its Human Data Stack, delivering deeply translatable insight across discovery, safety, biodistribution, and efficacy. Through partnerships with academic medical centers and organ procurement organizations, Revalia repurposes donated, non-transplantable organs into powerful research systems that accelerate therapeutic discovery. By plugging in with existing transplant infrastructure, Revalia has enabled donors who would otherwise not be able to donate for transplantation to donate their organs for research. Donors and their families can leave a lasting legacy by contributing to the next generation of curative therapies.

Since launching commercially in 2023, Revalia has quadrupled its revenue and recently signed two of the world’s top 10 pharmaceutical companies as customers. It also developed a first-of-its-kind human lung cancer model in partnership with LifeShare of Oklahoma and achieved key breakthroughs in organ perfusion, including a four-day kidney protocol.

“The ability to generate high-fidelity, human-specific data at scale is one of the most important advancements in biomedicine today,” said Brian Wilcove, Managing Partner at America’s Frontier Fund. “Revalia’s platform has the potential to not only transform clinical trials, but to strengthen national health resilience,” he added.

Revalia was founded by a multidisciplinary team of scientists, entrepreneurs, and operators. CEO Greg Tietjen, former tenure track professor at Yale, ran a renowned academic lab that was a world-leader in perfusion science. With a PhD in human organ perfusion from the University of Cambridge, Jenna DiRito brings deep experience in human organ research infrastructure. Kourosh Saeb-Parsy, Peter Buniak, and Helen Hughes add clinical and operational depth to the team. Milad Alucozai, a neuroscientist and first investor, joined the company to help scale it.

“This is about creating a new foundation for medicine, one built on human data, not animal models,” said Ben Yu, Managing Partner at Sierra Ventures. “That shift will change not just how we develop treatments, but how we understand biology itself,” he added.

Looking ahead, Revalia aims to serve as the foundational infrastructure for Human-Centered Drug Development – offering the insights, systems, and data needed to shift drug development away from animal models and toward truly human-first decision-making. The company’s long-term vision is to provide the infrastructure and insight needed to shift drug development to truly human-centered systems that are grounded in the real world problems care providers face every day.

For more information, visit https://revaliabio.com.

Media Contact:
contactus@revaliabio.com

SOURCE: Revalia Bio

View the original press release on ACCESS Newswire

MIAMI, FL / ACCESS Newswire / September 4, 2025 / The future in private jet charter travel is here and its name is Wilbur. PrivateJet.com, (PrivateJet.com LLC), the leading domain in private aviation, has launched the world’s first AI-powered private jet charter assistant. Engineered by a leading team of professionals, this unique proprietary system provides real-time estimates using internal data based on hundreds of thousands of quotes. That means no third-party data is used, providing customers with the most realistic, up-to-date, and competitive pricing in the industry.

The process is as simple as telling Wilbur when and where you want to travel, how many passengers, and whether it’s a one way or round-trip flight. Wilbur then recommends airports, detailed aircraft options across all categories with photos, and transparent pricing estimates – all in a matter of seconds. This advanced technology helps customers navigate any complexities of on-demand air charter by comparing aircraft types, different interiors and cabin sizes, passenger capacities, and onboard amenities.

Aptly named, Wilbur pays tribute to aviation pioneer Wilbur Wright, one of the legendary brothers who achieved the first powered, sustained, and controlled airplane flight. And like its namesake who revolutionized travel, AI Wilbur is transforming the booking process by making private jet chartering faster, smarter, and more accessible than ever before. The AI-powered system is designed to save users time and increase operational efficiency.

Privatejet.com Director of Sales Michael Loff said, “Wilbur enhances the customer experience by providing access to our database, empowering users to explore and identify the best options for their needs, all at their fingertips.”

Privatejet.com users are met with 24/7 white-glove customer service to access more than 6,000 aircraft spread across 240 models, connecting them to over 15,000 airports worldwide. The addition of Wilbur to Privatejet.com elevates the company’s mission to combine innovative technology with concierge service, setting a new standard in how luxury and business travel is booked and experienced.

Contact: Charter@privatejet.com

SOURCE: Privatejet.com

View the original press release on ACCESS Newswire